How Science Communication Can Optimize Adoption Of Next-generation Therapeutics
All eyes have been on the biopharmaceutical industry for nearly a year as the world followed the journey towards the development of an effective COVID-19 vaccine. Unfortunately, the good news of FDA’s decision to allow emergency use of the Pfizer-BioNTech and Moderna vaccine candidates also revealed the gravity of persistent public misconceptions regarding vaccines that […]
